Stocks/Funds/CIK 316011

LILLY ENDOWMENT INC

long-term holderconcentrated
Quarterly 13F filings · Latest period 2026-03-31 · CIK 316011
Assets
$84.52B
+6.6% YoY
Holdings
1
Lifetime alpha vs market
+21.59% annual
Average hold time
10.5 yr
median 10.5 yr

Quarterly history

Cum return +233% vs S&P +52% · α +180% lifetimeAUM $84.5B · peak $99.1BFlow $-411M (-0%)2016-062017-122019-062020-122022-062023-122025-062026-03
AUM ($B)fundS&P 500(gap = α)/ Flow in/out

Behavior signals (lifetime)

Dip response
-0.16%
trims when stocks drop
when a holding falls −10%+
Middle response
-0.42%
baseline attrition
Rally response
-1.58%
trims into rallies
when a holding rises +10%+

Top positions · 1

Ticker$ value% portYoYHold time
LLYEli Lilly and Company$84.52B100.0%+12.2%10.5 yr

Portfolio composition (YoY)

Industry mix
Drug Manufacturers - General100.0%+0.0pp$84.52B
Country
US100.0%+0.0pp
Top 5: 100.0% · Top 10: 100.0% · Top 25: 100.0%

Winners

TickerPrev $PnLYoY %
LLY$79.30B+9.59B12.2%

Losers

TickerPrev $PnLYoY %

Top buys this quarter · 0

No buys this quarter

Top sells this quarter · 1

LLY Eli Lilly and Company$270M

Quarterly history (TTM returns)

PeriodAUM# PosReturn (1yr)SPY (1yr)Alpha (1yr)Flow
2026-03-31$84.52B1+12.19%+17.59%-5.40%-0.41B
2025-12-31$99.08B1+40.25%+17.72%+22.53%-3.70B
2025-09-30$72.86B1-13.22%+17.52%-30.74%-0.56B
2025-06-30$74.85B1-13.31%+14.94%-28.25%-0.15B
2025-03-31$79.30B1+6.85%+8.30%-1.45%-0.86B
2024-12-31$74.80B1+33.30%+24.89%+8.42%-0.12B
2024-09-30$85.84B1+66.05%+36.04%+30.01%-0.54B
2024-06-30$88.15B1+94.49%+24.49%+70.00%-1.54B
2024-03-31$76.94B1+128.43%+29.62%+98.81%-0.81B
2023-12-31$58.16B1+60.91%+26.18%+34.73%-0.23B
2023-09-30$53.70B1+67.91%+21.57%+46.35%-0.68B
2023-06-30$47.38B1+46.37%+19.42%+26.95%-0.84B
2023-03-31$35.22B1+21.45%-7.82%+29.27%-0.25B
2022-12-31$37.66B1+13.46%+7.56%+5.90%-0.41B
2022-09-30$33.56B1+0.05%-4.93%+4.98%-0.23B
2022-06-30$33.77B1+13.61%-16.11%+29.72%-0.76B